Literature DB >> 16831965

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Sean J Pittock1, Brian G Weinshenker, Claudia F Lucchinetti, Dean M Wingerchuk, John R Corboy, Vanda A Lennon.   

Abstract

BACKGROUND: Neuromyelitis optica (NMO)-IgG is a specific autoantibody marker for NMO. It binds selectively to aquaporin 4 (AQP4), which is highly concentrated in astrocytic foot processes at the blood-brain barrier and is not restricted to optic nerve and spinal cord. Although it is conventionally believed that the brain is spared, brain imaging abnormalities are not uncommon in patients with NMO.
OBJECTIVE: To investigate the location of brain lesions that are distinctive for NMO with respect to the localization of AQP4 in mammalian brain.
DESIGN: Observational, retrospective case series.
SETTING: Clinical serologic cohort of patients tested for NMO-IgG for whom brain MRI images were available. PATIENTS: We identified 120 patients seropositive for NMO-IgG for whom brain magnetic resonance images were available. MAIN OUTCOME MEASURE: Magnetic resonance imaging abnormalities.
RESULTS: In 8 patients we observed recurring and distinctive magnetic resonance imaging abnormalities in the hypothalamic and periventricular areas that corresponded to brain regions of high AQP4 expression.
CONCLUSION: The distribution of NMO-characteristic brain lesions corresponds to sites of high AQP4 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831965     DOI: 10.1001/archneur.63.7.964

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  179 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 2.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Seronegative neuromyelitis optica after cardiac transplantation.

Authors:  Elecia Kim; Michael Van Vrancken; Mohamed Shaji; Osman Mir; Cedric W Spak; Manu Gupta; Sadat A Shamim
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

4.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

5.  AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

Authors:  S Siritho; I Nakashima; T Takahashi; K Fujihara; N Prayoonwiwat
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

6.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

7.  The history of neuromyelitis optica.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

Review 8.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 9.  What do we know about brain contrast enhancement patterns in neuromyelitis optica?

Authors:  Yeliz Pekcevik; Gunes Orman; In Ho Lee; Maureen A Mealy; Michael Levy; Izlem Izbudak
Journal:  Clin Imaging       Date:  2015-07-26       Impact factor: 1.605

Review 10.  Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Authors:  Meike Mitsdoerffer; Vijay Kuchroo; Thomas Korn
Journal:  Ann N Y Acad Sci       Date:  2013-04       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.